流感病毒的抗肿瘤作用及其细胞凋亡机制的探索

基本信息
批准号:39970830
项目类别:面上项目
资助金额:11.00
负责人:李明远
学科分类:
依托单位:四川大学
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:肖丽英,牟家琬,陈代云,曹国玉
关键词:
抗肿瘤作用细胞凋亡流感病毒
结项摘要

Background: Based on the theory that viral multipolication could be done if host cells provide resource, energy and apparatus for viral biosynthesis and the reports which said that influenza virus could induce apoptosis on MDCK and Hela cells, we hypothesized that influenza virus can kill tumour cells by inducing apoptosis. The hypothesis was proved by vitro and vivo experiments..Methods: At first, we cultured influenza virus by embryonated chicken eggs. The virus was added to the plates in which tumour cells reached 75~90% confluence, including Hela, Raji, SMMC-7721 and SPC-A-1 strains. The apoptosis was observed by EM, DNA fragment analysis, and flow cytometry. sFasL in the supernatant was measured by ELISA. We also inoculated the virus into the mice in which S180 had been burdened. Then the survival rate and time were observed. Apoptosis effect in tumour cells was also checked. The samples were harvested and measured cytokines, including IL-2, IL-6 and TNF-α.Results: In the vitro experiments, the apoptosis occurred in the four experimental tumour cell lines after influenza virus infection. The concentration of sFasL in the supernatants of cultured Hela cells also increased. We also found the same result in Newcastle disease virus (NDV) to cultured tumour cells. In the vivo experiments, both average living time and survival rate of the experimental group mice were longer and higher than that of control group significantly. The cytokines' level also were higher than control, especially IL-2. Apoptosis cells were detected in experimented tumour cell..Conclusion: The results suggested that influenza virus can induce tumour cells to apoptosis and activated T cell mediated immunity. This study enriched the contents of oncolytic virus and oncolytic virual therapy for tumours. We also hope to find one new agent for bio-therapy of tumours through this research. .

培养和分离各型流感病毒,用它们分别注射于瘤荷瘤小鼠的实体瘤局部、及作用于体外培养的肿瘤细胞,观察其对肿瘤细胞的抑制和杀灭作用,检测肿瘤细胞的形态学改变、Fas抗原偷蛲鱿赴鸇NA条带出现情况,阐明其可能的抗肿瘤作用机制。本研究把病毒对宿主细胞的抑制和引起细胞凋亡的作用借鉴到抗肿瘤作用上,希望利用流感病毒为肿瘤的生长治疗探索一条新途径。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

奥希替尼治疗非小细胞肺癌患者的耐药机制研究进展

奥希替尼治疗非小细胞肺癌患者的耐药机制研究进展

DOI:
发表时间:2020
2

TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老

TRPV1/SIRT1介导吴茱萸次碱抗Ang Ⅱ诱导的血管平滑肌细胞衰老

DOI:10.3969/j.issn.1001-1978.2022.02.019
发表时间:2022
3

血管内皮细胞线粒体动力学相关功能与心血管疾病关系的研究进展

血管内皮细胞线粒体动力学相关功能与心血管疾病关系的研究进展

DOI:10.13191/j.chj.2017.0028
发表时间:2016
4

SUMO特异性蛋白酶3通过调控巨噬细胞极化促进磷酸钙诱导的小鼠腹主动脉瘤形成

SUMO特异性蛋白酶3通过调控巨噬细胞极化促进磷酸钙诱导的小鼠腹主动脉瘤形成

DOI:10.3969/j.issn.1000-4718.2020.05.001
发表时间:2020
5

栀子苷对RAW264.7细胞胞饮和噬菌功能双向调节作用的初步观察

栀子苷对RAW264.7细胞胞饮和噬菌功能双向调节作用的初步观察

DOI:10.7655/NYDXBNS20191004
发表时间:2019

李明远的其他基金

批准号:81071362
批准年份:2010
资助金额:35.00
项目类别:面上项目
批准号:30671964
批准年份:2006
资助金额:28.00
项目类别:面上项目
批准号:29180006
批准年份:1991
资助金额:3.00
项目类别:专项基金项目

相似国自然基金

1

凋亡配体THANK的抗肿瘤作用及其机制研究

批准号:30171051
批准年份:2001
负责人:沈锋
学科分类:H1812
资助金额:18.00
项目类别:面上项目
2

三种裸子植物抗肿瘤活性成分及其细胞凋亡作用机制研究

批准号:20972168
批准年份:2009
负责人:张玉梅
学科分类:B0703
资助金额:32.00
项目类别:面上项目
3

高细胞密度下流感病毒引起的MDCK细胞凋亡机制研究

批准号:21206040
批准年份:2012
负责人:刘旭平
学科分类:B0812
资助金额:25.00
项目类别:青年科学基金项目
4

TPX2调控肝癌CD8+T细胞耗竭的作用机制研究及其抗肿瘤效应的探索

批准号:81772596
批准年份:2017
负责人:鲁小杰
学科分类:H1818
资助金额:45.00
项目类别:面上项目